Last reviewed · How we verify

implantology

University of Milan · FDA-approved active Biologic ✓ Verified May 2026

implantology is a Biologic drug developed by University of Milan. It is currently FDA-approved.

Implantology is the placement of dental implants by a dentist, specialist dentist in oral surgery, or oral and maxillofacial surgeons. This procedure is a part of the full range of dentistry that every licensed dentist is permitted to practice.

At a glance

Generic nameimplantology
SponsorUniversity of Milan
ModalityBiologic
Therapeutic areaOther
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about implantology

What is implantology?

implantology is a Biologic drug developed by University of Milan.

Who makes implantology?

implantology is developed and marketed by University of Milan (see full University of Milan pipeline at /company/university-of-milan).

What development phase is implantology in?

implantology is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing